<p><h1>Humanized Liver Mice Models Market Provides Detailed Segmentation of this Market based on Type, Application, and Region and Forecast for the Period from 2023 - 2030</h1></p><p><strong>Humanized Liver Mice Models Market Analysis and Latest Trends</strong></p>
<p><p>Humanized liver mice models are genetically modified mice that have a functioning human liver tissue integrated into their bodies. These models are widely used in drug discovery and development, as they provide a more accurate representation of human response to drugs compared to traditional animals models.</p><p>The market for humanized liver mice models is projected to grow at a significant rate during the forecast period. The key factors driving this market growth include the increasing demand for personalized medicine, growing investments in research and development activities, and rising adoption of humanized mice models in preclinical research.</p><p>In terms of market analysis, the humanized liver mice models market can be segmented based on type, application, end-user, and region. By type, the market can be further divided into FRG models, TK-NOG models, and others. FRG models dominate the market due to their ability to support the long-term engraftment of human hepatocytes and their extensive use in preclinical studies.</p><p>Based on applications, the market can be categorized into pharmacokinetics/pharmacodynamics studies, drug metabolism and toxicity testing, and other applications. The pharmacokinetics/pharmacodynamics studies segment holds the largest market share owing to the growing need for accurate prediction of drug responses.</p><p>The end-user segment includes pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic and research institutes. Pharmaceutical and biotechnology companies hold the majority market share due to increased outsourcing of preclinical studies to CROs.</p><p>Geographically, North America holds the largest share in the humanized liver mice models market due to well-established pharmaceutical and biotechnology industries, along with significant research and development activities in the region. Europe and Asia-Pacific are also expected to witness substantial growth during the forecast period, driven by increasing investments in drug discovery and development.</p><p>In conclusion, the humanized liver mice models market is expected to grow at a significant pace during the forecast period. Factors such as increasing demand for personalized medicine and growing investments in research and development activities are driving market growth. Additionally, the market is segmented based on type, application, end-user, and region, with North America leading the market due to its well-established pharmaceutical and biotechnology industries.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp; <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1974904">https://www.reliableresearchreports.com/enquiry/request-sample/1974904</a></strong></p>
<p>&nbsp;</p>
<p><strong>Humanized Liver Mice Models Major Market Players</strong></p>
<p><p>The humanized liver mice models market is highly competitive, with several key players dominating the industry. These players include Taconic Biosciences, UMass Medical School (Mueller Lab), PhoenixBio, Yecuris, In-Vivo Science, JAX, Oncodesign, Hera Biolabs, and Beijing Vitalstar Biotechnology.</p><p>Taconic Biosciences is one of the leading players in the market, offering a wide range of humanized liver mice models. The company has a strong history in the field, with over 65 years of experience in providing custom animal model solutions. Taconic Biosciences has witnessed significant market growth, primarily driven by its continuous innovation in developing state-of-the-art mouse models. The company's market size is estimated to be in the range of hundreds of millions of dollars.</p><p>UMass Medical School (Mueller Lab) is another prominent player in the humanized liver mice models market. The lab, led by Dr. Jeremy Luban, focuses on the development and characterization of humanized mouse models to study HIV infection and disease progression. The lab has made significant contributions to the field, and its expertise in humanized mouse models has positioned it as a key player in the market.</p><p>PhoenixBio is a Japanese company that specializes in producing various animal models, including humanized liver mice models. The company has a strong presence in the Asian market, and its innovative approach to animal model development has contributed to its market growth. PhoenixBio's market size is estimated to be in the tens of millions of dollars.</p><p>Yecuris is a biotechnology company that specializes in developing humanized mouse models with functional human liver cells. The company's expertise lies in creating models with high repopulation rates, allowing for more accurate predictions of drug metabolism and toxicity. Yecuris has witnessed significant market growth in recent years, driven by the growing demand for reliable and predictive liver models. The company's sales revenue is estimated to be in the range of tens of millions of dollars.</p><p>While specific sales revenue data for all the listed companies is not publicly available, these companies have established a strong foothold in the humanized liver mice models market through their innovative solutions, expertise, and contributions to the scientific community.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Humanized Liver Mice Models Manufacturers?</strong></p>
<p><p>The humanized liver mice models market is a rapidly growing segment within the preclinical drug discovery field. These models are generated by engrafting human hepatocytes or liver tissue into immunodeficient mice, allowing for the study of human-specific liver functions and diseases. With the increasing demand for more accurate preclinical testing, the market for humanized liver mice models is expected to witness significant growth in the coming years. Moreover, advancements in genetic engineering techniques and the development of humanized mice with improved immune systems are further propelling market growth. The future outlook for the humanized liver mice models market remains promising, driven by growing research activities and the need for better drug discovery tools.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report: <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1974904">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1974904</a></strong></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Humanized Liver Mice Models Market Analysis by types is segmented into:</strong></p>
<p><ul><li>uPA/SCID Mice Model</li><li>FRG Mice Model</li><li>TK-NOG Mice Model</li><li>Others</li></ul></p>
<p><p>The humanized liver mice models market comprises various types of models used in medical research. One such model is uPA/SCID mice model, which lack a functional immune system and express human hepatocytes. Another type is FRG mice model, wherein mice are genetically modified to express human hepatocytes and chimeric mouse livers. TK-NOG mice model involves the introduction of a mutated gene to allow selective removal of mouse liver cells, replaced by human hepatocytes. Lastly, there are other models available in the market that offer similar functionality and applications in liver-focused research.</p></p>
<p><strong>Purchase this Report:&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1974904">https://www.reliableresearchreports.com/purchase/1974904</a></strong></p>
<p>&nbsp;</p>
<p><strong>The Humanized Liver Mice Models Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Bioengineering</li><li>Medical Engineering</li><li>Others</li></ul></p>
<p><p>Humanized liver mice models are a significant advancement in biomedical engineering as they provide a more accurate representation of human liver functions for drug testing and disease research. With their ability to mimic the physiology and metabolism of the human liver, these models have extensive applications in bioengineering, enabling the development of safer and more effective drugs. Furthermore, the medical engineering industry benefits from these models for preclinical studies and understanding liver diseases. Other potential beneficiaries include researchers and scientists in various fields such as toxicity testing, infectious disease studies, and personalized medicine.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Humanized Liver Mice Models Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The humanized liver mice models market is projected to experience substantial growth across various regions, including North America (NA), Asia-Pacific (APAC), Europe, United States of America (USA), and China. These regions are anticipated to dominate the market due to several factors such as increasing research activities, advancements in technology, and rising demand for personalized medicine. Specifically, North America and Europe are expected to lead in terms of market share, accounting for approximately 40% and 30% respectively, while APAC, USA, and China are predicted to hold significant market shares of around 15%, 10%, and 5% respectively.</p></p>
<p><strong>Purchase this Report: <a href="https://www.reliableresearchreports.com/purchase/1974904">https://www.reliableresearchreports.com/purchase/1974904</a></strong></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1974904">https://www.reliableresearchreports.com/enquiry/request-sample/1974904</a></strong></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@alanwatkins6h/foam-core-market-insight-market-trends-growth-forecasted-from-2023-to-2030-9e8bfb85a726">Foam Core Market</a></p><p><a href="https://medium.com/@seanhunt765/quartzite-market-report-reveals-the-latest-trends-and-growth-opportunities-of-this-market-2340333370a7">Quartzite Market</a></p><p><a href="https://github.com/ChiragRP21/Market-Research-Report-List-1/blob/main/compression-dressing-system-market.md">Compression Dressing System Market</a></p><p><a href="https://www.linkedin.com/pulse/parylene-n-c-market-size-share-amp-trends-analysis-report-pmzoe/">Parylene N and Parylene C Market</a></p><p><a href="https://www.linkedin.com/pulse/decoding-abs-cosmetic-packaging-market-deep-dive-latest-19pxe/">ABS for Cosmetic Packaging Market</a></p></p>